Earnings Preview: Accuray to Report Financial Results Post-market on November 06
$Accuray(ARAY.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Accuray(ARAY.US)$ to post revenue of USD97.55M for 2025Q1, down 6.1%
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
Express News | Accuray Appoints Michael Murphy as Vp, Corporate Controller
Accuray Appoints Michael Murphy as VP, Corporate Controller
Accuray Announced That Results Of The Pace-B– Prostate Advances In Comparative Evidence – Trial Were Published In The New England Journal Of Medicine
New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men With Localized Prostate Cancer
Press Release: Accuray President and Chief Executive Officer Suzanne Winter Returns From Medical Leave of Absence
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife S7 System Medical Professional Training
Genolier Innovation Hub, an Innovative Global Healthcare Center, Is Inaugurated Today in Switzerland
Accuray | 10-K: FY2024 Annual Report
Here's Why You Should Retain Accuray Stock in Your Portfolio Now
Lake Street Keeps Their Buy Rating on Accuray (ARAY)
Express News | Accuray Inc: Fourth Amendment Reduces Available Revolving Commitments Available Under Amended Credit Agreement to No More Than $20 Mln
Express News | Accuray Inc: On Sept 12, Entered Into Fourth Amendment to Credit Agreement
Gifu Prefectural General Medical Center Achieves Milestone With Treatment of the First Cancer Patients in Japan Using the Accuray Radixact System and VitalHold Solution
Express News | Accuray Inc - Sandeep Chalke Will Serve as Interim CEO During Winter's Absence
Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
Accuray Secures CE Mark For Accuray Helix, A CT-Guided Helical Radiotherapy System
Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix